Quadrature Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,064	Closed	-$259K	–	1056
2025 Q1	$259K	Sell	1,064 -736	-41%	-$221K	0.01%	781
2024 Q4	$592K	Sell	1,800 -4,234	-70%	-$1.44M	0.01%	545
2024 Q3	$2.02M	Buy	6,034 +739	+14%	+$235K	0.05%	250
2024 Q2	$1.45M	Sell	5,295 -3,349	-39%	-$974K	0.02%	374
2024 Q1	$2.99M	Sell	8,644 -15,176	-64%	-$4.99M	0.05%	228
2023 Q4	$7.7M	Buy	23,820 +11,135	+88%	+$3.49M	0.14%	104
2023 Q3	$4.55M	Buy	12,685 +12,143	+2,240%	+$4.69M	0.09%	158
2023 Q2	$205K	Buy	542 +13	+2%	+$5.29K	﹤0.01%	823
2023 Q1	$254K	Sell	529 -25,946	-98%	-$12.1M	0.01%	711
2022 Q4	$11.1M	Buy	26,475 +16,654	+170%	+$6.72M	0.33%	69
2022 Q3	$4.1M	Buy	9,821 +3,923	+67%	+$1.96M	0.13%	161
2022 Q2	$2.92M	Sell	5,898 -9,893	-63%	-$5.15M	0.12%	175
2022 Q1	$8.89M	Buy	15,791 +13,166	+502%	+$7.94M	0.36%	69
2021 Q4	$1.98M	Buy	+2,625	New	+$1.96M	0.1%	149
2021 Q3	–	Sell	-2,767	Closed	-$1.78M	–	707
2021 Q2	$1.78M	Buy	2,767 +700	+34%	+$426K	0.07%	207
2021 Q1	$1.18M	Buy	+2,067	New	+$1.22M	0.06%	280
2020 Q4	–	Sell	-1,600	Closed	-$825K	–	830
2020 Q3	$825K	Buy	+1,600	New	+$810K	0.05%	390
2018 Q3	–	Sell	-1,528	Closed	-$441K	–	585
2018 Q2	$441K	Buy	+1,528	New	+$422K	0.04%	337
2018 Q1	–	Sell	-3,124	Closed	-$746K	–	600
2017 Q4	$746K	Buy	+3,124	New	+$757K	0.07%	266